Skip to main content

Bruce & Co., Inc.

SEC CIK
0001358331
Latest filing
Aug 14, 2026

Holdings in Q1 2023

Holdings as of Mar 31, 2023, filed May 12, 2023. Long positions only; changes compare share counts with Q4 2022.

Institution overview
Positions
37
0 vs. Q4 2022
Portfolio value
$366.9M
−$21.0M (−5.4%) vs. Q4 2022
Filed
May 12, 2023
SEC
Holdings of Bruce & Co., Inc. in Q1 2023
SecurityClassSharesValue% of portfolioShare changeActionHistory
UHAL.BU-Haul Holding CoCOM SER N640,530$33.2M9.1%−20,000−3.0%ReducedHistory
MRKMerck & Co., Inc.COM300,372$32.0M8.7%−2,328−0.8%ReducedHistory
ABBVAbbVie Inc.Stock191,743$30.6M8.3%−10,757−5.3%ReducedHistory
FPL Group Inc302571104COM345,114$26.6M7.2%−2,386−0.7%Reduced–
CMSCMS Energy CorpCOM416,755$25.6M7.0%−1,745−0.4%ReducedHistory
DUKDuke Energy CORPStock260,319$25.1M6.8%−881−0.3%ReducedHistory
XELXcel Energy IncStock371,754$25.1M6.8%−746−0.2%ReducedHistory
PFEPfizer IncStock538,626$22.0M6.0%−4,074−0.8%ReducedHistory
TAT&T Inc.Stock1,130,254$21.8M5.9%−1,746−0.2%ReducedHistory
ALLAllstate CorpStock166,844$18.5M5.0%−11,456−6.4%ReducedHistory
ABTAbbott LaboratoriesStock166,843$16.9M4.6%−757−0.5%ReducedHistory
Paratek699374AA2Cv 4.75%–$12.3M3.3%–––
AAPLApple Inc.Stock63,801$10.5M2.9%−699−1.1%ReducedHistory
IIINInsteel Industries IncCOM343,423$9.55M2.6%+69,423+25.3%AddedHistory
AVAAvista CorpCOM205,000$8.70M2.4%00.0%UnchangedHistory
Bausch Health91911K102Common925,780$7.50M2.0%−5,220−0.6%Reduced–
FOCLEdap TMS SASPONSORED ADR565,652$6.26M1.7%00.0%UnchangedHistory
UHALU-Haul Holding CoCOM74,764$4.46M1.2%−291−0.4%ReducedHistory
PRTKParatek Pharmaceuticals, Inc.COM1,556,247$3.95M1.1%−1,065−0.1%ReducedHistory
Acorda Theraputics00484MAB2Cv 6.0%–$3.25M0.9%–––
NEMNEWMONT CorpStock65,600$3.22M0.9%+600+0.9%AddedHistory
SUPNSupernus Pharmaceuticals, Inc.COM82,105$2.97M0.8%−10,000−10.9%ReducedHistory
KODKodiak Sciences Inc.COM473,000$2.93M0.8%+473,000NewHistory
Accelerate Diagnostics, Inc00430HAB8NOTE 2.500% 3/1–$2.77M0.8%–––
SIRISirius XM Holdings Inc.COM657,843$2.61M0.7%00.0%UnchangedHistory
ASHAshland Inc.COM15,000$1.54M0.4%00.0%UnchangedHistory
FATEFate Therapeutics IncCOM200,000$1.14M0.3%+143,000+250.9%AddedHistory
LVTXLAVA Therapeutics NVSHS671,874$1.12M0.3%+571,874+571.9%AddedHistory
MNKDMannkind CorpCOM NEW195,073$799.8K0.2%00.0%UnchangedHistory
IGMSIGM Biosciences, Inc.COM55,000$755.7K0.2%00.0%UnchangedHistory
OGNOrganon & Co.Stock31,470$740.2K0.2%00.0%UnchangedHistory
MASS908 Devices Inc.COM68,286$587.3K0.2%00.0%UnchangedHistory
VTRSViatris IncStock59,539$572.8K0.2%−733−1.2%ReducedHistory
CRBUCaribou Biosciences, Inc.COM100,000$531.0K0.1%+100,000NewHistory
PSNLPersonalis, Inc.COM150,000$414.0K0.1%+100,000+200.0%AddedHistory
RLIRli CorpCOM2,400$319.0K0.1%00.0%UnchangedHistory
WBDWarner Bros. Discovery, Inc.Stock14,811$223.6K0.1%+301+2.1%AddedHistory

Sold out since Q4 2022 (2)

Positions held at the end of Q4 2022 that are gone from this filing.

Positions of Bruce & Co., Inc. sold out since Q4 2022
SecurityClassShares in Q4 2022Value in Q4 2022% of portfolio in Q4 2022History
Amryt Pharma PLC03217L106SPONSORED ADS315,182$2.30M0.6%–
Novavax Inc670002AB0NOTE 3.750% 2/0–$590.0K0.2%–